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Legionella pneumophila is the most common cause of the severe respiratory infection known
as Legionnaires’ disease. However, the microorganism is typically a symbiont of free-living
amoeba, and our understanding of the bacterial factors that determine human pathogenicity
is limited. Here we carried out a population genomic study of 902 L. pneumophila isolates
from human clinical and environmental samples to examine their genetic diversity, global
distribution and the basis for human pathogenicity. We find that the capacity for human
disease is representative of the breadth of species diversity although some clones are more
commonly associated with clinical infections. We identified a single gene (lag-1) to be most
strongly associated with clinical isolates. lag-1, which encodes an O-acetyltransferase for
lipopolysaccharide modification, has been distributed horizontally across all major phyloge-
netic clades of L. pneumophila by frequent recent recombination events. The gene confers
resistance to complement-mediated killing in human serum by inhibiting deposition of
classical pathway molecules on the bacterial surface. Furthermore, acquisition of lag-1 inhibits
complement-dependent phagocytosis by human neutrophils, and promoted survival in a
mouse model of pulmonary legionellosis. Thus, our results reveal L. pneumophila genetic traits
linked to disease and provide a molecular basis for resistance to complement-mediated
killing.
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L egionella pneumophila is a γ-proteobacterial speciesthat parasitises free-living amoeba in freshwaterenvironments1,2. L. pneumophila hijacks the phagocytic
process in amoebae and human alveolar macrophages by subverting
host cellular mechanisms to promote intracellular replication3.
Legionella infections are a global public health concern presenting as
either a severe pneumonia known as Legionnaires’ disease or Pontiac
fever, a self-limiting flu-like syndrome4–7. Importantly, recent sur-
veillance studies have indicated a steady increase of legionellosis
incidences globally8,9.
L. pneumophila infection in humans is considered to be the
result of accidental environmental exposure and the selection for
pathogenic traits among L. pneumophila is likely to be driven by
co-selective pressures that exist in its natural habitat10. The
pivotal mechanism required for intracellular replication is the
type IV secretion system (T4SS) that is conserved across all
known members of the genus Legionella11,12. A very large
repertoire of effector proteins in different combinations is enco-
ded by Legionella species and can be secreted by this system to
mediate critical host-pathogen interactions11. In addition, the
ability to infect eukaryotic cells has evolved independently many
times11. Despite this, less than half of all currently described
Legionella species have been reported to cause human disease13.
Furthermore, there is an over-representation of a single serogroup
(Sg-1) of L. pneumophila in human infections, which is respon-
sible for more than 85% of all reported cases of legionellosis14. Sg-
1 strains can be further subdivided phenotypically using mono-
clonal antibodies (mAbs) that recognise various components of
the lipopolysaccharide (LPS). The most prevalent mAb subtype in
human infections is associated with an LPS O-acetyltransferase
enzyme encoded by the lag-1 gene (lpg0777), which confers an
LPS epitope recognised by the mAb 3/1 from the Dresden mAb
panel15,16. lag-1 has previously been reported to be associated
with clinical isolates of L. pneumophila but its role in patho-
genicity remains a mystery17–21.
Recently, it was shown that a very limited number (n= 5) of L.
pneumophila sequence types (ST)s are responsible for almost half
of all human infections and that these clones have undergone very
recent emergence and expansion22. In addition, it was shown that
recombination between the dominant STs has led to sharing of
alleles that may be beneficial for human pathogenicity22. How-
ever, the genetic basis for the enhanced human pathogenic
potential of these STs is unknown. Early studies identified the
capacity for some L. pneumophila strains to resist killing in
human serum, a phenotype that may correlate with increased
virulence23. However, the molecular mechanism of strain-
dependent serum resistance by L. pneumophila has remained
elusive for over 30 years.
Here, we employ a population genomic analysis of L. pneu-
mophila isolates from clinical and environmental sources to
investigate the diversity of genotypes associated with human
disease. Further, we employ genome-wide association analyses to
identify genetic traits associated with human pathogenic strains
revealing lag-1 to be the most strongly associated determinant of
human pathogenic potential in L. pneumophila. We demonstrate
that acquisition of lag-1 has occurred widely across the species by
recent horizontal gene transfer and recombination, leading to
strains that have enhanced resistance to complement-mediated
killing, neutrophil phagocytosis and survival in a murine model of
pneumonia.
Results and discussion
The potential for human infection is distributed across the L.
pneumophila species phylogeny. In order to examine the
diversity of L. pneumophila associated with human clinical
infection in comparison to those from environmental sources, we
carried out whole-genome sequencing of 397 clinical and envir-
onmental L. pneumophila subsp. pneumophila isolates from an
archived collection (1984 to 2015) of Legionella species held at the
Scottish Haemophilus, Legionella, Meningococcus & Pneumo-
coccus Reference Laboratory, Scottish Microbiology Reference
Laboratory, Glasgow (SHLMPRL) as detailed in the Methods
section. The dataset included 166 clinical isolates from infected
patients, primarily from sputum and bronchoalveolar lavages
(BAL). The proportion of clinical isolates from the less severe
Pontiac fever form of legionellosis is unknown but is presumed to
be very limited due to low hospitalisation rates for these infec-
tions. In addition, we included sequences from 231 environ-
mental isolates of L. pneumophila subsp. pneumophila from water
sources such as cooling towers and plumbing systems sent to the
reference laboratory for routine testing and surveillance (Sup-
plementary Data 1). Some of the isolates classified as environ-
mental in our dataset were sampled as part of an outbreak
investigation and therefore may in some cases be related to
clinical isolates. Accordingly, the power to identify traits that
differentiate clinical and environmental groups may be negatively
affected. To place the SHLMPRL isolates into context of the
known global diversity of L. pneumophila subsp. pneumophila
isolates, we included 500 assembled whole genomes that were
available in the public database (NCBI Genbank). We constructed
a Maximum-Likelihood phylogenetic tree from 139,142 core
genome single nucleotide polymorphisms (SNP), which indicates
the segregation of the L. pneumophila subsp. pneumophila
population into seven major clades (Fig. 1) each supported by a
minimum of one and a maximum of two sub-clusters defined by
Bayesian Analysis of Population Structure (BAPS) analysis
(Supplementary Fig. 1). Isolates from the SHLMPRL collection
were distributed among all major clades indicating that the iso-
lates are representative of the global species diversity (Fig. 1).
Although recombination has played an important role in diver-
sification of the species, complicating the accurate reconstruction
of the phylogeny24, the major phylogenetic clusters are consistent
with those identified in previous population studies employing
fewer isolates25,26. Recombination is more likely between phylo-
genetically related (and genetically similar) isolates, which may
amplify the phylogenetic signal that defines these major groups27.
Of the 166 clinical isolates, 80 belonged to the five most common
sequence types (ST) implicated in human infections (ST1, 23, 36/
37, 47 and 62). The remaining 86 clinical isolates were from STs
distributed across all seven major phylogenetic clusters (Fig. 1).
These data indicate that although only 5 STs are responsible for
almost half of all infections, the other half of human infection
isolates come from diverse genetic backgrounds distributed across
the species. Of note, five clusters from distinct outbreaks of
Legionnaires’ disease in Scotland between 1985 and 201228–30
originated from different clades (Fig. 1). Similarly, the 231
environmental isolates are also distributed across all major phy-
logenetic groups (Fig. 1). Notably, 35% (81 of 231) of environ-
mental isolates belong to one of the five clinically dominant STs
suggesting that at least a third of all environmental L. pneumo-
phila from the sampled sources in Scotland have human patho-
genic potential. Overall, although some STs appear to have higher
human pathogenicity, our findings support the understanding
that the capacity for causing human disease is widely distributed
across diverse L. pneumophila genetic backgrounds.
Genome-wide association analysis of L. pneumophila reveals
genetic traits associated with human pathogenicity. The factors
that contribute to the enhanced human infectivity or transmis-
sibility of some L. pneumophila clones are unknown. Our
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strategy, to address this gap in understanding, involved sequen-
cing of large numbers of genetically diverse environmental iso-
lates, affording for the first time, a large-scale genome-wide
association study (GWAS) of clinical vs environmental isolates to
explore the bacterial genetic basis for human clinical disease.
Initially, we performed systematic subsampling on our dataset to
reduce the number of closely related isolates originating from the
same type of source, either clinical or environmental, while
retaining genetic diversity. This step removes over-represented
endemic or epidemic clonal lineages in the dataset that arise from
opportunistic, convenience sampling and also represents an
additional control for a stratified bacterial population structure.
From this reduced dataset (n= 452), we used the programme
SEER to identify a total of 1737 k-mers that were enriched (sig-
nificantly associated, p < 0.05) among clinical isolates in com-
parison to environmental isolates. Mapping to the L. pneumophila
Philadelphia 1 Sg-1 reference genome (Accession number: AE017354)
[https://www.ncbi.nlm.nih.gov/nuccore/AE017354.1] revealed that
39% (n= 673) of the k-mers aligned to a region of the genome
spanning between loci lpg0748 and lpg0781 representing an 18 kb
cluster of genes involved in LPS biosynthesis and modification
































Fig. 1 Human clinical isolates of L. pneumophila are widely distributed across the global species diversity. A maximum-likelihood phylogeny of 902
isolates based on 139,142 core genome SNPs divides the subspecies into seven major clades that are also supported by BAPS clustering. Isolates linked to
five major outbreaks that have occurred in Scotland, UK between 1985 and 2012 originated from different lineages are indicated. In addition, isolates
associated with sporadic cases of human infection have also emerged from diverse genetic backgrounds across all major clades. For reference, the position
of five major disease associated clones (ST1, 23, 36/37, 47 and 62) and well-characterised reference genomes are indicated. The tree scale indicates the
number of subtitutions per site.
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significantly enriched k-mer that mapped to it: namely, lpg0751,
lpg0752, lpg0755, lpg0758, lpg0759, lpg0760, lpg0761, lpg0762, lpg0766,
lpg0767, lpg0768, lpg0769, lpg0771, lpg0772, lpg0773, lpg0774, lpg0775,
lpg0777 (lag-1), lpg0778, lpg0779, lpg0780 and lpg0781 (Fig. 2 and
Supplementary Table 1). Two additional conservative SEER analyses
using more stringently subsampled datasets resulted in a smaller
number of significantly enriched k-mers (205 and 61, respectively),
that converge on a single gene within the LPS cluster (lpg0777, lag-1)
that encodes an O-acetyltransferase involved in modification of the
O-antigen of the L. pneumophila Sg-1 LPS (Supplementary Fig. 2). To
account for the random nature of the subsampling algorithm, mul-
tiple iterations were performed at the middle threshold, and the
distribution of significant k-mers was shown to be consistent across
all (Supplementary Fig. 2b).
To corroborate the initial findings of the k-mer based SEER
approach, we employed a different GWAS method (SCOARY)
that examined the distribution of orthologous genes using the
pan-genome pipeline ROARY32,33. Consistent with SEER, this
approach also indicated that the Sg-1 LPS biosynthesis genes were
enriched among clinical isolates with lag-1 exhibiting the
strongest statistical support over other Sg-1-associated LPS genes
(Supplementary Table 1). The corrected (Benjamini–Hochberg)
p-value for lag-1 is several orders of magnitude lower (9.74E-11)
than other Sg-1 LPS genes that were above the significance
threshold (lpg0779: 2.35E-05, lpg0780: 2.35E-05, lpl0815/lpg0774:
3.84E-05 and lpg0767: 6.92E-05). As mentioned, lag-1 has
previously been reported to be prevalent among clinical
isolates17–21. However, our large objective pangenome-wide
analysis of the L. pneumophila species indicates that of all
11198 accessory genes, lag-1 has the strongest association with
clinical isolates, suggesting a major role in human disease. In
total, 80.1% of clinical isolates contained lag-1 compared to 30.8%
of environmental isolates (Supplementary Fig. 3). Sg-1 LPS genes
were found in high-frequency throughout the population, and in
each major lineage indicating species-wide gene transfer. The Sg-
1 LPS cluster is also found in other subspecies of L. pneumophila
that can infect humans, such as subspecies fraseri and pascullei
but has not been reported in other species of Legionella34,35. Here,
we observed that lag-1 can be associated with different
combinations of Sg-1 LPS genes and still express the expected
lag-1 phenotype represented by the mAb 3/1-specific epitope
(Dresden mAb scheme) (Supplementary Data 1)36,37. However,
genetic instability and phase variation has been reported to affect
the mAb phenotype between closely related strains38,39. One
mechanism of phase variation is the excision of a 30 kb genetic
element that results in a change in mAb specificity manifested by
a loss of virulence in guinea pigs and loss of resistance to
complement40,41.
Recombination has mediated the dissemination of three
dominant lag-1 alleles across the L. pneumophila species. It has
been reported since the 1980s that isolates expressing the epitope
recognised by the mAb 3/1 are more frequently associated with
isolates from community-acquired and travel-associated
infections37,42,43. However, the pathogenic basis for this asso-
ciation remains a mystery. In order to further investigate the role
of the clinically-associated gene lag-1, we examined its diversity
and distribution across the 902 L. pneumophila genomes
employed in the current study. In total, three major allelic var-
iants of lag-1 that had been previously identified to be repre-
sentative of reference strains, Philadelphia, Arizona, and Corby,
respectively, were identified43. In our dataset, variant 1 (Phila-
delphia), was present in 195 (22%), variant 2 (Arizona) in 195
(22%) and variant 3 (Corby) in 178 (20%) of the 902 isolates
examined (Fig. 3a). Each variant was distributed across the
phylogeny, with variant 1 found in 3 major clades (1, 4 and 7) and
variants 2 and 3 identified among isolates of all 7 major clades
(Fig. 3a). Of note, clade 2 has the lowest frequency (12%) of
isolates encoding the lag-1 gene and is also characterised by an
under-representation of clinical isolates (31%). In addition to the
three major lag-1 alleles, we identified a relatively small number
(n= 40) of derived minor allelic variants that differ by <1%
nucleotide identity from any of the 3 major variants (Supple-
mentary Table 2). Of these, only 10 are predicted to encode for
full-length proteins suggesting most are likely to be non-
functional pseudogenes. The occurrence of these three allelic
variants of lag-1 gene and their widespread distribution across the
species phylogeny indicates frequent horizontal dissemination of
























































































Fig. 2 GWAS reveals gene sequences associated with clinical isolates of L. pneumophila. Manhattan plot showing the genomic position of k-mers
significantly associated with clinical isolates. The LPS biosynthesis and modification locus (822,150bp–855,010 bp: lpg0751-lpg0781) in the Philadelphia 1
reference genome (AE017354) [https://www.ncbi.nlm.nih.gov/nuccore/AE017354.1] is represented and genes with significant k-mer associations
coloured in red, with lag-1 in blue.
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pressure for the conservation of lag-1 sequence and function. The
nucleotide sequence identity of 89%–95% between the three
allelic variants is lower than the average nucleotide sequence
identity for genes across the species, which is typically >95%
(Supplementary Table 2). The closest homologue of lag-1 in the
NCBI non-redundant protein database shares only 45% amino
acid sequence identity and encodes a putative acyltransferase
present in an environmental species of the genus Pseudomonas.
The selective advantage for L. pneumophila to maintain lag-1 in
the environment is still unclear. It has been proposed that the
increased hydrophobicity of LPS when acetylated by O-acetyl-
transferase may enhance L. pneumophila survival in amoebae
vacuolar compartments44. An alternative hypothesis is that L.
pneumophila is evolving the capacity to transmit between humans
or from humans to the environment as proposed by David
et al.22. In which case, the recent spread of lag-1 across the
phylogeny may have been driven by selection in the human host
and contributed to the recent expansion of successful clones.
Horizontal transfer and recombination events involving the 18 kb





























































Fig. 3 lag-1 variants have disseminated horizontally across the species. a Core-genome SNP-based phylogenetic tree indicating the distribution of the 3
major allelic variants of lag-1 across Sg-1 strains. Variant 1 (Philadelphia, Red), Variant 2 (Arizona, Green) and Variant 3 (Corby, Blue). Each major clade is
associated with at least two different lag-1 alleles. Minor alleles that are within >99% nucleotide sequence identity to a major variant are shown with lighter
colours. Isolates not containing lag-1 are coloured grey. The tree scale indicates the number of subtitutions per site. b A neighbour-net phylogenetic
network indicating recombination of Sg-1 LPS genes including lag-1. The network was drawn using uncorrected P-distances with the equal angle method in
Splitstree from a concatenated alignment of 10 conserved Sg-1 LPS genes that were significantly associated with clinical isolates (9405 positions).
Orthologs of 10 LPS cluster genes were extracted from 16 phylogenetically representative isolates coding 3 different variants of lag-1, 7 isolates missing lag-
1 and 9 reference genomes (Lens, HL06041035, Philadelphia-1 [ST36], Paris [ST1], Corby, Alcoy, Pontiac [ST62], Lorraine [ST47], ST23).
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including between Philadelphia-1 (ST36) and Paris (ST1)45,46. In
addition, a microarray-based comparative genomic study identi-
fied this genomic region to be associated with human disease47.
To investigate the potential role of recombination in the dis-
tribution of the LPS genes including lag-1, we carried out a split
network analysis based on the concatenated alignment of 10 LPS
biosynthesis genes that were present in 23 representative isolates
from across the phylogeny encoding different lag-1 variants
(Fig. 3b). This analysis revealed extensive reticulation consistent
with recombination across the gene cluster and identified hor-
izontal transfer of LPS genes between three major clinical
sequence types, ST23, ST47 and ST62, respectively (Fig. 3b). This
network analysis revealed that even highly similar LPS bio-
synthesis gene clusters, such as those found in isolates 4454,
Corby and Alcoy or 4616 and 4718, encode different variants of
lag-1, consistent with recent gene conversion of lag-1. We also
identified three examples of closely related genomes (average
nucleotide identity across the genome of >99.8%) that exhibited a
signature of homologous recombination affecting lag-1 and the
surrounding genomic region (Supplementary Fig. 4). These
findings expand on a previously proposed mechanism of lag-1
gene deletion by Kozak and colleagues43 and demonstrate that
recombination can restore a disrupted or missing lag-1 gene or
replace one functional lag-1 variant with another (Supplementary
Fig. 4).
A comparison of re-assortment rates across major phylogenetic
lineages showed no significant differences between LPS and non-
LPS genes across the L. pneumophila genome (p= 0.6275). This
suggests that recombination is active on a genome-wide scale, in
agreement with earlier analyses of rates of recombination across
the genome45,46 (Supplementary Fig. 5 and Supplementary
Data 2). Taken together, these findings highlight the wide
dissemination of lag-1 and other LPS genes by recombination.
lag-1 confers resistance to killing by human plasma. Our
population data indicate that lag-1 gene has the highest statistical
support of all accessory genes for a role in human pathogenicity.
Consistent with this, previous studies have reported an epide-
miological correlation between lag-1 or its mAb 3/1-recognised
epitope and clinical disease17–21 but a mechanistic understanding
of its role in pathogenesis has proved elusive. Of note, an early
study described an increased ability of an endemic nosocomial L.
pneumophila strain to survive complement killing when com-
pared to an environmental strain collected from the same medical
facility23. More recently, resistance to complement-mediated
killing has been proposed as a key fitness advantage that enables
the Philadelphia Sg-1 strain to establish infections compared to
other serogroups48. To investigate this phenotype in the context
of lag-1 genotype, we examined resistance to killing in human
plasma for the aforementioned 23 Sg-1 L. pneumophila strains
selected to represent the diversity of lag-1 genotypes from across
the phylogeny. We observed that all strains lacking a lag-1 gene
were susceptible to killing in plasma, whereas groups of isolates
containing lag-1 variants exhibited enhanced resistance, inde-
pendent of the lag-1 variant encoded (Fig. 4a).
Within our dataset, we identified a group of epidemiologically-
related isolates from a single Scottish healthcare facility typed as
ST5 (a single locus variant of ST1), which were predicted to vary
with regard to lag-1 functionality. ST5 has only been found in this
location, to date. The earliest isolates obtained from a nosocomial
outbreak in 1984/198530 contained variant 3 (Corby) of the lag-1
gene and all were found to express the mAb 3/1 epitope
(Supplementary Data 1). In contrast, 16 of 19 environmental
isolates from the same healthcare facility 12 to 21 years later (1997
to 2006) contained multiple independent mutations in lag-1
predicted to disrupt functionality. Specifically, a nonsense
mutation (L48*), an insertion of a transposase, and the
acquisition of a deleterious substitution (H28L) (Fig. 4b), each
correlated with a lack of reactivity with mAb 3/1 from the
Dresden panel classification (Supplementary Data 1). Consistent
with our previous findings (Fig. 4a), the presence of a functional
LPS O-acetyltransferase in this epidemiological cluster also
correlated with resistance to killing in human plasma, whereas
isolates with a non-functional lag-1 were susceptible to killing,
independent of the type of deactivating mutation (Fig. 4c). Of
note, no clinical episodes of disease were identified to be caused
by this epidemiological cluster after 1985, and all clinical isolates
contained a functional lag-1 gene. The identification of multiple
independent mutations associated with loss of lag-1 function
suggests a selection pressure that drives the inactivation of the
lag-1 gene and LPS O-acetylation in this environment. The trend
of lag-1 gene loss or deactivation was not observed among
longitudinal ST1 healthcare facility-associated isolates from a
cluster sequenced in a recent study by David and colleagues24.
However, a study on starvation of L. pneumophila in ultrapure
water showed that in a short-term period, the viable cell numbers
of all mAb 3/1-positive strains decreased strongly compared to
the other strains suggesting a negative selection for lag-1 function
in some water environments49. Overall, these data indicate that
the presence of a functional lag-1 correlates with enhanced
resistance to serum killing.
To investigate the role of lag-1 in mediating resistance to serum
killing, we introduced each of three major lag-1 variants encoded
on an expression plasmid (pMMB207) into the strain 4681 that
contains a non-functional lag-1 gene due to the insertion of a
transposase. Introduction of each lag-1 variant led to expression
and LPS 8-O-acetylation as confirmed by flow cytometric
detection of the mAb 3/1 epitope (Fig. 5a, b). Strikingly,
complementation of the strains with each lag-1 variant resulted
in resistance to killing in human serum (Fig. 5d). In order to test
this phenomenon in a distinct strain background, we introduced
the lag-1 variant 1 into the lag-1-negative strain 4312, which
contains a 1 bp deletion resulting in a frameshift at position 156.
Similarly, lag-1 expression conferred resistance to killing in
human serum (Supplementary Fig. 6). Consistent with this, we
observed a decrease in human C3 deposition at the surface of the
lag-1 expressing bacteria when compared to the isogenic lag-1-
negative strain, at levels similar to the wild-type lag-1-positive
isolate 3656 (Supplementary Fig. 7). Of note, it was previously
reported that a wild-type lag-1-positive isolate and a sponta-
neously derived lag-1 mutant demonstrated similar levels of
resistance to serum killing20. We were unable to obtain the
relevant strains, but we speculate that the discordance with our
findings could be due to phase-variable expression of LPS19 or
differences in transcriptional levels of lag-1 gene that have been
previously observed depending on culture conditions50.
lag-1 confers resistance to killing by the classical complement
pathway. We next investigated if a specific complement pathway
was responsible for the serum killing of the Sg-1 mAb 3/1-
negative L. pneumophila. As a similar inhibitory effect of lag-1 on
bacterial killing was observed in both serum and plasma, we
employed serum for these experiments to facilitate the use of
commercially available depleted serum samples. EDTA can be
used to inhibit the classical, lectin and alternative pathways via
chelation of both Ca2+ and Mg2+, whereas chelation with EGTA/
Mg2+ inhibits the Ca2+-dependent classical and lectin pathways
only, leaving the alternative pathway unaffected (Fig. 6a). Killing
assays in human serum in the presence of either EDTA or EGTA/
Mg2+ resulted in complete abrogation of lag-1-negative strains
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susceptibility to complement, and no difference in cell viability
compared to incubation in heat-inactivated serum, suggesting the
alternative complement pathway is insufficient to kill L. pneu-
mophila (Fig. 6b). To distinguish the role of the classical from the
lectin pathway, killing assays were performed in the presence of
mannose that competes for the association of mannose binding
lectin (MBL) with the bacterial surface and blocks the lectin
complement pathway51. Using this approach, there was no effect
on bacteria viability, indicating that the lectin pathway is not
required for L. pneumophila Sg-1 killing, consistent with the
previous report that MBL polymorphisms are not associated with
a higher risk for legionellosis52. The exclusion of the lectin
pathway suggests the essential role of the classical pathway in
the complement killing of L. pneumophila. To confirm this
finding we depleted serum of C1q, required for the classical
pathway, resulting in loss of serum-mediated killing (Fig. 6b). It
is noteworthy that we also observed an increase in bacterial via-
bility in the presence of Factor B-depleted serum (Fig. 6b),
implying a possible role for the alternative pathway in amplifi-
cation of classical pathway activation as previous described for
Streptococcus pneumoniae53. The impact of this pathway in L.
pneumophila serum killing may be strain-dependent as indicated
by the difference in the impact of Factor-B depletion on the
2 strains examined (Fig. 6b). Previously, purified L. pneumophila
LPS was reported to activate both classical and alternate path-
ways, primarily through the activation of the classical pathway
dependent on natural IgM antibodies54. In another study, com-
plement C1q protein was demonstrated to bind to the major
outer membrane protein (MOMP) of L. pneumophila, activating
complement in an antibody-independent way55.
lag-1 expression enhances resistance to neutrophil phagocy-
tosis, and survival in a murine model of pulmonary legio-
nellosis. Classical pathway complement activity exists in healthy
human BAL, despite the relatively low concentration of some
complement proteins56, and exposure to aerosolized LPS leads to
a rapid increase of the level of these proteins in the lung of human
volunteers57. The importance of this innate immune mechanism
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Fig. 4 Presence of functional lag-1 correlates with resistance to killing in human plasma. a Representative L. pneumophila isolates containing allelic
variants 1, 2, and 3 of lag-1 (depicted in red, green, and blue, respectively) or lag-1-negative (depicted in grey) were incubated with human plasma (coloured
bars and dots) or heat-inactivated plasma (open bars and dots) for 1 h at 37 °C. Each dot represents an average cfu count in plasma from a single donor
(n= 7 donors for strain 4470, n= 6 for strains 4454, 4471, 4472, 4616, 4537, 4597; n= 5 for strains 4310, 4682, 4449, 4403, 4415, 4312; n= 4 for
strains 4552, 4438, 4718, 4562, 4821, 4450 and n= 3 for strains 4546, 4819, 4719, 4813). Mean+/− SEM, One-way Anova with Holm-Sidak’s multiple
comparisons test between Plasma and Heat-inactivated plasma for the same strain. One-way Anova with Tukey’s multiple comparisons test for differences
between the variants. *p < 0.05, **p < 0.01, ****p < 0.0001. Source data and exact p-values are provided in the Source Data file. b Schematic representation
of the multiple natural lag-1 independent deactivating mutations in epidemiologically-related isolates. In blue—functional lag-1, with dots— lag-1 with
His28Leu mutation, with lines—lag-1 truncated by an insertion sequence in aa 251, in grey—lag-1 truncated by a premature stop codon. c Isolates with lag-1
mutations show increased susceptibility to killing in human plasma. Closely related isolates from the same hospital-associated cluster were incubated with
human plasma (coloured and patterned bars and dots) or heat-inactivated plasma (open bars and dots) for 1 h at 37 °C. Each dot represent an average cfu
count in plasma from a single donor (n= 9 donors for strain 3956; n= 7 for strain 4443; n= 6 for strain 4681; n= 4 for strains 3947, 3959, 4567, 4451,
4474, 4568, 4595 and n= 3 for all other strains). Mean+/− SEM, One-way Anova with Holm-Sidak’s multiple comparisons test between Plasma and
Heat-inactivated plasma for the same strain, *p < 0.05, **p < 0.01, ****p < 0.0001. Source data and exact p-values are provided in the Source Data file.
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with deficiencies in complement proteins or complement recep-
tors have recurrent respiratory infections58. The role of the
complement system in lung immune defences extends beyond the
proteolytic cascade associated with bacterial lysis, as opsonisation
with complement C3b protein induces phagocytosis of opsonized
targets by neutrophils and macrophages59. Accordingly, to test
the effect of lag-1 expression on phagocytosis of L. pneumophila
by neutrophils, human blood purified neutrophils were incubated
with fluorescein isothiocyanate (FITC)-labelled L. pneumophila
strains in the presence of non-immune human serum (Fig. 7a to
d). We examined naturally occurring lag-1-positive (n= 3) and
lag-1-negative (n= 3) strains from diverse phylogenetic groups,
and observed elevated FITC mean fluorescence intensity (MFI) in
neutrophils infected with lag-1-negative strains compared to lag-
1-positive strains indicating a lag-1-dependent reduction in
internalisation (Fig. 7a). Further, introduction of the lag-1 gene
on the pMMB207 expression plasmid significantly reduced neu-
trophil phagocytosis (Fig. 7c and Supplementary Fig. 6). The
same effect was observed in neutrophils infected with the natu-
rally occurring strains expressing DSred via pSW001 (Supple-
mentary Figs. 8 and 9). Consistent with these findings, confocal
microscopy of neutrophils infected with lag-1 expressing strains
had lower numbers of internalised bacteria when compared to
neutrophils infected with lag-1-negative strains (Fig. 7b, d). Taken
together, these data demonstrate a role for lag-1 in resistance to
neutrophil phagocytosis. It was previously shown that lag-1



































































Fig. 5 lag-1 confers resistance to complement-mediated killing of L. pneumophila. a and b Introduction of any lag-1 gene variant leads to mAb 3/1 epitope
expression. Detection of mAb 3/1 epitope by flow cytometry in (a) WT and (b) isogenic mutants of L. pneumophila isolates expressing the lag-1 variant 1, 2
or 3. c and d lag-1 expression confers serum complement resistance to L. pneumophila strains with non-functional lag-1 gene. Isolates were incubated with
human serum or heat-inactivated serum for 1 h at 37 °C. Each point represents an average of triplicate CFU counts of a single sera donor (n= 3). Bars
represent mean+ SEM. One-way ANOVA, Tukey’s multiple comparisons test, *p < 0.05, ****p < 0.0001. Comparison to Empty vector isogenic strain
represented on the top of the bars. Comparison to Empty vector isogenic strain represented on the top of the bars. Source data and exact p-values are


























Fig. 6 The classical pathway is essential for complement-mediated killing of L. pneumophila. a Simplified schematic representation of the complement
pathways and the inhibitors used in this study. Made using Lucidchart. b Inhibition of both classical and alternative pathways confers L. pneumophila
resistance to complement killing in human serum. 3956, 4451, 4681::Empty vector isolates were incubated with 90% heat-inactivated serum, serum, serum
with EDTA, EGTA/Mg2+ or mannose, Factor B- or C1q-depleted serum for a 1 h at 37 °C. Each point represents an average of three technical replicates for
a single biological replicate (n= 8 biological replicates for heat-inactivated serum and serum; n= 6 for serum with EDTA and with EGTA/Mg; n= 4 for
serum with Manose, Factor B- and C1q-depleted serum). Statistical analysis when compared to serum on top of the bars. One-way ANOVA, Tukey’s
multiple comparisons test, **p < 0.01 ****p < 0.0001. Source data and exact p-values are provided in the Source Data file.
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expression is associated with an increase in ability of L. pneu-
mophila to adhere and, consequently, penetrate into Acantha-
moeba castelani membranes60. However, the ability of LPS to
inhibit phagosome maturation in A. castellanii was reported to be
independent of a functional lag-161. Our data suggest that that
internalisation by neutrophils is inhibited by lag-1 and a
requirement for serum suggests an effect that is complement-
dependent (Supplementary Fig. 9). Therefore, the ability of lag-1-
positive L. pneumophila strains to escape complement deposition
correlates with the capacity to escape phagocytosis. These data are
consistent with the findings of early L. pneumophila studies,
where the L. pneumophila strain Philadelphia 1 (lag-1-positive)
was demonstrated to be resistant to complement and neutrophil
killing in the absence of specific antibodies62,63. Of note, there is
increasing evidence for the pivotal role of neutrophils in the
resolution of L. pneumophila lung infections, and either neu-
trophil depletion or blockage of recruitment to infected lungs
renders mice susceptible to L. pneumophila64–68.
In order to test the role of lag-1 in the pathogenesis of
legionellosis in vivo we used an established murine model of
pneumonia69. C56BL/6 mice were intranasally infected with L.
pneumophila strain 4681 containing either the empty plasmid or
plasmid expressing the lag-1 variant 3. Mice infected with the lag-
1-expressing strain exhibited higher bacterial burden in the lungs
at 96 h post infection compared to mice infected with the lag-1-
negative isogenic strain (Fig. 7e). These data indicate that
acquisition and expression of lag-1 enhances L. pneumophila
survival during infection of the lung.
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Fig. 7 lag-1 confers resistance to human neutrophil phagocytosis and enhances surival in a murine model of pneumonia. a to d lag-1 confers resistance
to human neutrophil phagocytosis. WT lag-1-positive and -negative strains expressing DsRed fluorescent protein, as well as isogenic mutants of L.
pneumophila isolates expressing the lag-1 variant 1, 2 or 3, were stained with FITC and pre-incubated with 10% human serum 15min prior incubation with
human neutrophils for 30min. a and b Phagocytosis was evaluated by measuring neutrophils FITC fluorescence by flow cytometry. Each point represents a
technical replicate for a single donor. Data are representative of three independent experiments. L. pneumophila strains expressing lag-1 variant 1, 2, or 3 are
represented in red, green, or blue, respectively. Strains that do not express a functional lag-1 gene are represented in grey. Non-infected (NI) neutrophils
are represented in black. Bars represent mean+/− SEM. One-way ANOVA, Dunnett’s multiple comparisons test to non-infected control or to Empty
vector, **p < 0.01, ****p < 0.0001. Source data and exact p-values are provided in the Source Data file. c and d Representative images of L. pneumophila-
infected human neutrophils obtained by confocal microscopy and maximum intensity algorithm. Bacteria are represented in green, cytoplasmic membrane
in red and nucleus in blue. e lag-1 expression increases L. pneumophila lung survival. C57BL/6J mice were intranasally infected with 1 × 106 L. pneumophila
cells in 40 μL of PBS and bacterial numbers in the lungs evaluated 96 h post infection. Each point represents an individual animal (n= 4 in each group).
Data are presented as mean+/− SEM. Two-tailed Mann–Whitney t-test *p < 0.0286. Source data are provided as a Source Data file.
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Taken together, our data indicate that L. pneumophila lag-1
mediated inhibition of complement deposition, disrupts the
innate immune response via inhibition of complement-mediated
lysis and inhibition of neutrophil phagocytosis, promoting
survival in vivo.
Conclusion
The steady global increase in L. pneumophila infections is wor-
risome and studies that explore the evolutionary basis of
increased pathogenicity can provide insights into the nature of
the public health threat posed. Here we have employed a com-
bined large-scale population level study of clinical and envir-
onmental isolates, along with functional ex vivo and in vivo
analyses to reveal the evolutionary and functional basis for serum
resistance in L. pneumophila. The apparent selective advantage
conferred by lag-1 for disease in humans is intriguing in the
context of its environmental reservoir. It is feasible that lag-1
provides a functional advantage in its natural amoebal host as
reported by Palusinska-Szysz et al., and that co-selection occurs
for enhanced pathogenicity in humans60. Alternatively, David
et al previously proposed that the recent expansion of L. pneu-
mophila in man-made water systems and global spread of
selected clones is consistent with possible human-to-human or
human-to-environmental dissemination22. If indeed some L.
pneumophila clones are evolving towards human colonisation
and transmission, lag-1 may represent a key human host-
adaptive trait. Finally, we suggest that the identification of a
specific modification of LPS that is required for resistance to
classical complement-mediated killing, inhibits phagocytosis by
neutrophils and promotes survival in vivo, could inform the
design of novel therapeutic approaches that subvert the capacity
of L. pneumophila to resist innate immune killing during severe
human infection.
Methods
Bacterial culture. L. pneumophila Sg-1 isolates from the Scottish Haemophilus,
Legionella, Meningococcus & Pneumococcus Reference Laboratory (SHLMPRL),
Scottish Microbiology Reference Laboratories (SMiRL), Glasgow collection were
grown on buffered charcoal yeast extract plates (Legionella CYE agar base-Oxoid,
BCYE Growth Supplement SR0110-Oxoid) for 3 days at 37 °C. Three colonies were
inoculated is of supplemented yeast extract broth (YEB, Yeast extract—Fluka,
BCYE Growth Supplement SR0110-Oxoid) for 24 h at 37 °C 200 rpm. Strains were
subcultured by transferring 150 µL of the previous inoculation into 15 mL of YEB
at 37 °C 200 rpm until it reaches O.D. 600 nm ≈ 0.8. When necessary, media was
supplemented with 10 µg/mL of chloramphenicol (Sigma-Aldrich) for plasmid
maintenance. After submission of the first version of the manuscript, the BCYE
Growth Supplement SR0110 from Oxoid was discontinued. The data from Sup-
plementary Fig. 10 was obtained during revision with bacteria cultured with the
alternative BCYE Growth Supplement LS0053 (E&O Laboratories Limited) to post-
exponential phase O.D. 600 nm ≈ 1.4, and on Legionella BCYE with GVPC pre-
poured plates (PP0870, E&O Laboratories Limited). Escherichia coli cells were
cultured at 37 °C in Luria-Bertani (LB) broth or agar (Melford) supplemented with
10 µg/mL of chloramphenicol (Sigma-Aldrich) or 100 µg/mL of ampicillin (Sigma-
Aldrich). For blue-white colony screening, LB agar plates were spread with 2%
X-gal (Melford).
Whole-genome sequencing. Four-hundred seventy-four Legionella isolates from
the SHLMPRL isolate collection were recovered from frozen stocks and sent to
MicrobesNG (microbesng.uk, Birmingham, United Kingdom) for DNA extraction
and whole-genome sequencing as follows: plated cultures of each isolate were
inoculated into a suspension of plastic beads in a cryopreservative (Microbank™,
Pro-Lab Diagnostics UK, United Kingdom). Three beads were washed with
extraction buffer containing lysozyme (final concentration 0.1 mg/mL) and RNase A
(ITW Reagents, Barcelona, Spain) (final concentration 0.1 mg/mL), incubated for
25min at 37 °C. Proteinase K (VWR Chemicals, Ohio, USA) (final concentration
0.1mg/mL) and SDS (Sigma-Aldrich, Missouri, USA) (final concentration 0.5% v/v)
were added and incubated for 5 min at 65 °C. Genomic DNA was purified using an
equal volume of SPRI beads and resuspended in EB buffer (Qiagen, Germany).
DNA was quantified with the Quant-iT dsDNA HS kit (ThermoFisher
Scientific) assay in an Eppendorf AF2200 plate reader (Eppendorf UK Ltd, United
Kingdom). Genomic DNA libraries were prepared using the Nextera XT Library
Prep Kit (Illumina, San Diego, USA) following the manufacturer’s protocol with
the following modifications: 2 ng of DNA were used as input, and PCR elongation
time was increased to 1 min from 30 s. DNA quantification and library preparation
were carried out on a Hamilton Microlab STAR automated liquid handling system
(Hamilton Bonaduz AG, Switzerland). Pooled libraries were quantified using the
Kapa Biosystems Library Quantification Kit for Illumina on a Roche light cycler 96
qPCR machine. Libraries were sequenced with the Illumina HiSeq using a 250 bp
paired end protocol.
Sequence processing and analysis. Reads were trimmed with Trimmomatic (v0.36)
using default settings and de novo assembly was performed using SPAdes (v3.10.0) and
contigs were reordered with Mauve Contig Reorderer (Muave v2.4.0)70. Gene anno-
tation and functional prediction for each assembly was generated using Prokka (v1.12).
The quality of whole-genome sequencing was assessed using Quast (v4.5) and genomes
that exceeded the following metrics were selected as high-quality assemblies for ana-
lyses. (i) Minimum 1.5 Mbp aligned to the L. pneumophila Philadelphia reference (total
aligned length), (ii) Maximum duplication ratio of 1.03 (based on distribution), (iii)
Minimum total length of contigs larger than 50 Kbp is 1Mbp. To maximise the fraction
of core genome that can be aligned, isolates belonging to the minor subspecies, (L.
pneumophila subsp. fraseri, L. pneumophila subspecies pascullei and L. pneumophila
subspecies raphaeli) were not included in downstream analyses. Whole-genome
sequences are available on the European Nucleotide Archive (ENA) database under
Bioproject number PRJEB31628 [https://www.ebi.ac.uk/ena/browser/view/
PRJEB31628]. Functional prediction of non-synonymous mutations in lag-1 were
predicted using PROVEAN (v1.1.3)71.
Twelve genes from the LPS cluster, specific to Sg-1 and overlapped by k-mers
enriched in clinical isolates (lpg0762, lpg0766, lpg0767, lpg0768, lpg0771, lpg0772,
lpg0773, lpg0777, lpg0778, lpg0779, lpg0780, lpg0781). Orthologs of these 12 genes
were identified. Genes that were not conserved in all 23 genomes analysed were
removed (lpg0771 and lpg0777). Paralogs of lpg0778 were also removed. Genes were
translated and aligned at the codon level using TranslatorX and Mafft. Alignments
for all 12 genes were concatenated. Phylogenetic networks were generated using
uncorrected P-distances with the equal angle method in Splitstree v4.14.672.
Sequence alignments were visualised in Artemis Comparison Tool v.17.0.1 and
figures generated with Easyfig v2.2.273,74.
Genome-wide association analyses. Five-hundred five high-quality publicly
available genome assemblies of L. pneumophila subsp. pneumophila were down-
loaded on the 2nd of March 2017 for inclusion in these analyses. Quality criteria
for inclusion of published genomes: fewer than 200 contigs of 1 kb or longer, less
than 1.03 duplication ratio, not a subspecies or taxonomic outlier (bright green or
grey clade), contigs >50 Kb add up to at least 1 Mbp, not >700 uncalled bases per
100 Kb. At least 3.2 Mbp in length.
From the combined dataset of 902 isolates, we were able to extract metadata
describing the isolation source for 758 isolates (environmental or clinical). A ML
phylogenetic tree was then constructed using RAxML (v8.2.10) from the 1.8 Mbp
core genome alignment generated using Parsnp v1.2 (https://github.com/marbl/
parsnp). This phylogenetic tree was used as input for the subsampling approach.
An automated subsampling algorithm was used to reduce the redundancy of the
dataset by iteratively removing one of each pair of isolates, which had the same
source type. We implemented this algorithm in a modified version of a phylogeny-
based dataset reduction tool called Treemmer (downloaded: 8th March 2018)75.
The modified subsampling script is available on github.com/bawee/Treemmer.
Specifically, we added the ability to take into account phenotypic categories (i.e.,
clinical or environmental) before iteratively removing one taxon from each pair of
the most closely related taxa in the phylogeny. This was repeated until the
minimum distance between the pairs of isolates with the same phenotype reached a
user-defined threshold. This approach was performed with increasing minimum
patristic distance thresholds between pairs on the tree, ranging from 0.0001 (≈180
SNPs), 0.001 (≈1800) and 0.01 (≈18,000 SNPs). The subsampled datasets contained
452 (60%), 382 (50%) and 353 (47%) of the original isolates, respectively.
GWAS analysis based on k-mer enrichment was performed using SEER
(v1.1.3alpha)76. The frequency of k-mers between 12 and 100 bp long were counted
with fsm-lite v1.0 (-m 12 -M 100). Only k-mers present in 5% and 95% of the total
number of isolates (-s < 5%> -S < 95%>) were used and -maf 0.05 (minimum allele
frequency) was used when performing the SEER analysis. The frequency and
distribution in clinical and environmental isolates were evaluated individually for
each k-mer. Pan-GWAS was performed using the homologue clusters generated by
ROARY (v3.12.0) using the following settings (-i 95 -s)32. The association analyses
were calculated using SCOARY (v1.6.9)33. The following thresholds were used to
identify the highest-scoring associations: Naive p-value < 0.05, p-value after
Bonferroni correction <0.05, Benjamini–Hochberg p-value < 0.05 and Empirical
p-value after 500 label-switching permutations <0.05 (-e 500).
Molecular biology. For lag-1 cloning, primers (Variant 1: Fwd- GGC CGA ATT
CGT AAG GAA AAA TAA TTT ATC, Rev- CCC GGA TCC TTA TGT TGA
ATA AGC TAA CTT GTT TGA TGT; Variant 2: Fwd – GGC CGA ATT CGT
AAG GAA AAA TAA TTT ATC, Rev – ATG GAT CCT TAC ATC ATC ACC
ATC ATC ATT GTT GAA TAA GCC AAC; Variant 3: Fwd – GGC CGA ATT
CAC ATG CAA GAA TAA TTTA, Rev – CCC GGA TCC GCT TAC GTA ATA
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TAA GCT AAC TTA TTT GAT GTGEcoRI and BamHI restriction sites in bold)
were used to amplify a 1221 bp fragment of chromosomal DNA from L. pneu-
mophila strains 4454, 4449 and 4471, encoding the variant 1, 2 and 3 of lag-1 allele
and upstream region, respectively. These fragments were blunt cloned with Stra-
taClone Blunt PCR Cloning kit (Agilent) into vector pSC-B and transformed into
E. coli. Plasmids from transformants were purified with Monarch Plasmid DNA
Miniprep Kit and digested with EcoRI and BamHI enzymes (New England Bio-
Labs). lag-1 gene was ligated to pMMB207 using T4 DNA ligase (New England
BioLabs) and both pMMB207::lag-1 and empty plasmid were electroporated into
the electrocompetent mAb 3/1-negative strains 4681 and 4312 using a Gene Pulser
II (Bio-Rad) following published protocols77. To confirm O-acetyltransferase
activity of the lag-1 cloned bacteria, transformed and positive control strains were
fixed in 10% formalin (VWR) for 20 min and incubated with 1:100 of mouse mAb
3/1 (Dresden panel) for 30 min in ice prior incubation with 1:100 polyclonal
AlexaFluor 488 conjugated donkey anti-mouse IgG (H+ L) (Cat no. A21202,
ThermoFisher Scientific). After incubation on ice for 30 min, the bacteria were
washed and resuspended in PBS for flow cytometry analysis. DsRed fluorescent
protein expression was introduced into WT lag-1-positive and -negative strains by
electroporation with pSW001 plasmid (pMMB207C, ΔlacIq, constitutive dsred)78.
DsRed expression was confirmed by flow cytometry. Formaldehyde-fixed samples
were analysed on a BD LSRFortessa X-20 flow cytometer (BD biosciences) and data
analysed using FlowJo software (v10).
Ethics statement. Ethical approval for the collection of blood from anonymous
donors was granted by the University of Edinburgh Research Ethics Committee.
This study was reviewed by the University of Edinburgh, College of Medicine
Ethics Committee (2009/01) and subsequently renewed by the Lothian Research
Ethics Committee (11/AL/0168). Written informed consent was received from all
volunteers participating in the study. No compensation was provided to the
volunteers. All animal experiments were approved by governmental animal welfare
committees by the LaGeSo (Landesamt für Gesundheit und Soziales) Berlin. All
experiments are assigned to project G0334/17.
Plasma and serum killing assays. Human blood was obtained from healthy
volunteers in syringes treated with anticoagulant citrate dextrose. Plasma was obtained
by centrifuging whole blood for 15min at 25 °C at 1200 × g without the centrifuge brake
and collecting the layer above the buffy coat. Normal serum was collected from human
blood obtained from healthy volunteers in BD Vacutainer serum tubes. Tubes were
centrifuged for 10min at 25 °C 1200 × g and the supernatant collected. Plasma and
serum were stored following immediate freezing at –80 °C. Samples used were negative
for anti-L. pneumophila antibodies as determined by standard diagnostic serology
methods (immune fluorescence test). The ability of L. pneumophila strains to resist
killing by human plasma and serum was determined by incubating 1 × 105 bacterial
cells in 90% plasma or serum at 37 °C for 60min. Serial dilutions were plated in
duplicate on BCYE media, incubated at 37 °C for 3 days before enumeration. Heat
inactivation of plasma was carried out by incubation at 56 °C for 30min in a water bath.
Both plasma, serum, heat-inactivated plasma and heat-inactivated serum were cen-
trifuged at 4000 × g for 20min at 4 °C prior use. Inhibition of complement pathways
was carried out by adding 12.5mM EDTA (Sigma-Aldrich), 12.5mM EGTA/Mg2+
(Sigma-Aldrich) or 100mM mannose (Acros Organics) to normal human serum or by
using C1q- and Factor B-depleted serum (Pathway Diagnostics). GraphPad prism v7
was used for statistical analysis.
C3 binding assays. For analysis of C3 deposition on the surface of L. pneumophila,
bacteria were grown to post-exponential phase and fixed in 10% formalin (VWR)
for 20 min. Nunc maxisorp ELISA plates were coated with 1 × 107 bacteria per well
overnight at 4 °C, blocked with 1% w/v bovine serum albumin (Sigma-Aldrich) in
PBS for 2 h and incubated with serial dilution of human serum for 2 h at room
temperature. Binding of C3 at the surface of the bacteria was determined by
incubating with 1:100 FITC conjugated goat F(ab’)2 anti-human C3 complement
(Protos Immunoresearch, Cat no. 365) for 2 h at room temperature and fluores-
cence detected in using the CLARIOstar fluorescence plate reader (BMG Labtech).
GraphPad prism v7 was used for statistical analysis.
Neutrophil phagocytosis assay. Human venous blood was obtained from healthy
volunteers in syringes treated with anticoagulant citrate dextrose and the isolation
of neutrophils was performed by Ficoll/Histopaque centrifugation79. L. pneumo-
phila-DsRed strains and L. pneumophila isogenic strains were labelled with 0.5 mg/
mL of FITC (Sigma) solution for 30 min on ice in the dark. After several washes
with PBS to remove any non-associated FITC, the bacteria were incubated with
10% normal human serum for 15 min at 37 °C before incubation with 2.5 × 105
purified neutrophils (MOI 10). Infection was maintained at 37 °C, 5% CO2 with
orbital shaking at 600 rpm for 30 min. Cells were then fixed in 10% formalin
(VWR) for 20 min and kept in PBS for flow cytometry analysis. Samples were
analysed on a BD LSRFortessa X-20 flow cytometer using the FACSDiva software
v9 (BD biosciences) and data analysed using FlowJo software (v10). Neutrophils
were selected by their FSC/SSC profile and doublets excluded using FSC-H/FSC-A
ratios. MFI was calculated in the total single cell population (Supplementary Fig. 9).
GraphPad prism v7 was used for statistical analysis.
Confocal microscopy. L. pneumophila-infected neutrophils were incubated for
20 min with WGA-AF555 (Invitrogen) and with Hoechst 33342 (Thermo Scien-
tific) for 5 min for cytoplasmatic membrane and nucleus staining, respectively.
Cells were attached to a microscope slide using cytospins and analysed using the
Zeiss LSM 710 inverted confocal. The images were obtained using a maximum
intensity projection algorithm.
Murine pulmonary infection. All mice used were 12–14 weeks old, female WT on
a C57BL/6J background. Mice were either purchased from Charles River or from
institutional breeding stock at the Charité-University Medicine, Berlin. Upon
transfer to the animal unit, mice were kept in ventilated cages at a conditioned
room temperature at 22 °C+/− 2 °C and humidity at 55%+/− 5%. A dark/light
cycle of 12 h/12 h was maintained. All experiments were approved by the LaGeSo
(landesamt für Gesundheit und Soziales) Berlin. Anaesthetised mice were intra-
nasally infected with 1 × 106 L. pneumophila in 40 µL of PBS. 96 h post infection,
mice were anesthetised and euthanized through final blood withdrawal. Lungs were
flushed via the pulmonary artery with sterile 0.9% NaCl, subsequently removed and
homogenised using a cell strainer (100 µM, BD Bioscience). For determination of
bacterial counts, the lung homogenates were lysed with 0.2% Triton X-100. Serial
dilutions were plated on BCYE agar and incubated for 3 days at 37 °C.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The sequence data that support the findings of the study have been deposited in the
European Nucleotide Archive (ENA) database under Bioproject number PRJEB31628
[https://www.ebi.ac.uk/ena/browser/view/PRJEB31628]. Accession numbers of each
genome used is listed in Supplementary Data S1. A source data file is provided with this
paper. Source data are provided with this paper.
Code availability
We have implemented a modified version of the subsampling software Treemmer
(https://github.com/fmenardo/Treemmer)75, which is available at http://github.com/
bawee/Treemmer.
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